Antifibrinolytic therapy to reduce haemoptysis from any cause
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrinolytic Therapy to Reduce Haemoptysis From Any Cause." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434311/all/Antifibrinolytic_therapy_to_reduce_haemoptysis_from_any_cause.
Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434311/all/Antifibrinolytic_therapy_to_reduce_haemoptysis_from_any_cause. Accessed November 23, 2024.
Antifibrinolytic therapy to reduce haemoptysis from any cause. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434311/all/Antifibrinolytic_therapy_to_reduce_haemoptysis_from_any_cause
Antifibrinolytic Therapy to Reduce Haemoptysis From Any Cause [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434311/all/Antifibrinolytic_therapy_to_reduce_haemoptysis_from_any_cause.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrinolytic therapy to reduce haemoptysis from any cause
ID - 434311
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434311/all/Antifibrinolytic_therapy_to_reduce_haemoptysis_from_any_cause
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -